Newsroom
307 articles
WarningsThe Medicines and Healthcare products Regulatory Agency (MHRA) uncovered and shut down the UK’s first illegal weight loss medicine factory during a raid on a Northampton warehouse. This…
ImportantThe UK’s Innovative Licensing and Access Pathway (ILAP) aims to help patients get promising and much-needed new medicines more quickly. Announced by the Medicines and Healthcare products Regulatory…
Trending topicsThe Medicines and Healthcare products Regulatory Agency (MHRA) has launched three government-funded initiatives that aim to make medicine development and regulation safer and more efficient through the use…
Trending topicsArtificial intelligence (AI) continues to redefine the future of healthcare, from detecting cancer faster to improving diagnostic accuracy across hospitals. The UK’s Medicines and Healthcare products Regulatory Agency…
WarningsThe FDA is now raising awareness regarding administration of tranexamic acid injections to be limited only to intravenous administration. There have been case reports where tranexamic acid was…
ImportantEisai GmbH, in agreement with the European Medicines Agency (EMA), has updated the MRI monitoring schedule for LEQEMBI (lecanemab) 100 mg/mL concentrate for infusion, a treatment for early…
WarningsThe European Medicines Agency (EMA) in coordination with The Federal Institute for Drugs and Medical Devices (BfArM) has raised concerns regarding Caspofungin containing products, after finding that patients…
Drug ApprovalsOn October 8, 2025, the U.S. Food and Drug Administration (FDA) approved Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adults with cutaneous squamous cell carcinoma (CSCC) at high…
Drug ApprovalsThe Saudi Food and Drug Authority (SFDA) has approved the registration of Qalsody (tofersen) for the treatment of adults with amyotrophic lateral sclerosis (ALS) linked with mutations in…
WarningsThe U.S. Food and Drug Administration (FDA) is taking proactive steps to protect public health following alarming reports of diethylene glycol (DEG) and ethylene glycol (EG) contamination in…
Trending topicsThe Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have announced the early rollout of their accelerated aligned pathway…
Drug ApprovalsThe U.S. Food and Drug Administration (FDA) has approved lurbinectedin (Zepzelca) in combination with atezolizumab (Tecentriq), or with atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza), as a maintenance treatment for…
WarningsThe European Medicines Agency (EMA) has announced new safety measures for finasteride- and dutasteride-containing medicines to decrease the risk of suicidal ideation. These updates aim to increase awareness…
ImportantThe SFDA launched a dedicated webpage on its website that provides access to draft guidelines under development for public consultation and private sector feedback, along with the officially…
Trending topicsOn October 3, 2025, the FDA launched a pilot prioritization program to speed up the review of abbreviated new drug applications (ANDAs) for companies that manufacture and test…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP